Montlake Bioscience Inc. — Form D
Montlake Bioscience Inc. of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-01. The offering totals $25.0M, of which $11.3M was reported sold. Industry: Other.
Offering
- Filed: 2018-11-01
- Form: D
- Accession: 0001757681-18-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $11.3M
- Remaining: $13.7M
- Minimum investment: $250K
- Investors: 8
- Date of first sale: 2018-10-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-324837
Issuer
- Name: Montlake Bioscience Inc.
- CIK: 0001757681
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2018
- Address: 222 KAREN AVE #3807, LAS VEGAS, NV, 89109
- Phone: (702)353-7331
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Baxter Baldwin | Director | LAS VEGAS, NV |
| Pete Findley | Director | LAS VEGAS, NV |
| Jeremy Kiefer | Executive Officer | LAS VEGAS, NV |
More